Healthcare >> CEO Interviews >> December 14, 1998

John T. Spitznagel – Roberts Pharmaceuticals (rpc)

JOHN T. SPITZNAGEL joined Roberts in March 1996 as Executive Vice President, Worldwide Sales and Marketing. He has served on the Company's Board of Directors since July 1996 and was elected to the position of President and Chief Executive Officer on September 11, 1997. Mr. Spitznagel served as President of Reed and Carnrick Pharmaceuticals from September 1990 through July 1995. In 1989 and 1990, he served as Chief Executive Officer of BioCryst Pharmaceuticals, Inc. and from 1979 through 1989, he held various positions with Wyeth-Ayerst Laboratories, advancing from Marketing Director to Senior Vice President of Marketing and Sales. Mr. Spitznagel was employed by Roche Laboratories from 1971 through 1979 and by Warner-Chilcott Laboratories from 1966 through 1971 in various sales, marketing and management positions. Mr. Spitznagel received his undergraduate degree from Rider University and an M.B.A. from Fairleigh Dickinson University. Profile
TWST: Could you begin with a brief overview of Roberts Pharmaceuticals?

Mr. Spitznagel: Roberts is an integrated and growing pharmaceutical

company. We're involved in the development,